Colour enhancement

From PsychonautWiki
Jump to navigation Jump to search

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
6-APDB
Coluracetam
DOC
Experience:800 seeds LSA - My First Trip Ever
Phenylpiracetam
Methallylescaline
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
4-HO-DiPT
LSM-775
25I-NBOH
Experience:4x 200ug tabs - You do not need to understand
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
2C-T-21
DOM
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
Psilocin
5-MeO-DiPT
Experience:337mg DMT fumarate - A Day With DMT
4-HO-DET
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
Memantine
2C-I
Experience:250mg DXM - DXM Itch and Trip Report
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
4-HO-MPT
Tree.jpgJapanese Garden by Anonymous
LSD
2C-T-7
1P-ETH-LAD
1P-LSD
ETH-LAD
4-HO-EPT
ALD-52
Experience:4-AcO-DMT + 200mg Pill
Experience:BK-2C-B - Various experiences
MiPLA
GABAergic hallucinogens
Piracetam
Mescaline
Experience:25mg Deschloroketamine - My first time orally dosing DCK
2C-P
Cannabis
EPT
3C-E
5-MeO-DiBF
3-MeO-PCE
Amanita muscaria
25B-NBOH
3-MMC
JWH-073
TMA-6
Experience:4-HO-MiPT / A care free psychedelic getaway
Pramiracetam
Oxiracetam
Paradise island by Xanny.jpgParadise island by Subsentience
4-AcO-MiPT
AL-LAD
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
25I-NBOMe
Pregabalin
Bromo-DragonFLY
MDMA
4-AcO-MET
MDEA
Chameleon.jpgChameleon by Anonymous.
Experience:4.5g - The Grand Introduction to Beauty and Fear
Experience:3-MeO-PCP - Extreme psychosis
Experience:1050 µg 1cP-LSD - The matrix
LSZ
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
PRO-LAD
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
2C-E
DOB
THJ-018
4-HO-MiPT
Experience:120mg - Garden of The Gods
Experience:300µg AL-LAD - Don't worry, because you're everyone!
4-FA
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
Selective serotonin reuptake inhibitor
Experience:~150mg MDA(oral) - a case of mistaken identity
MiPT
Experience:1mg 25c-NBOMe - Experiment in my room
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
Βk-2C-B
DET
ΑMT
25N-NBOMe
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
Experience:1000 Morning Glory seeds - Rediscovering the Self
LSA
Proscaline
Psilocybin mushrooms
5-MeO-DALT
THJ-2201
Ibogaine
5-Hydroxytryptophan
Experience:3g mimosa / 3g syrian rue - Connecting with my body
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
MPT
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
Efavirenz
25C-NBOH
2C-T-2
25C-NBOMe
2C-H
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
Chur City in Switzerland.jpgChur, Switzerland by Naps284
Omberacetam
Enhancement of colour rose.jpgRose by Chelsea Morgan
JWH-018
MDA
Allylescaline
PARGY-LAD
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
4-HO-MET
4-AcO-DMT
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
1B-LSD
TMA-2
4-AcO-DET
Experience:300µg LSD - Togetherness and the Silent Dusk
6-APB
Aniracetam
Experience:40mg - Brothermind and the Forest's Hand
4-AcO-DiPT
25D-NBOMe
DOI
DiPT
4-HO-DPT
Experience:25mg 3-MeO-PCP - Enhanced film experience
2C-C
5-MeO-MiPT
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
2C-B-FLY
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
Phenethylamine (compound)
DPT
MET
Ayahuasca
2C-D
Bufotenin
5F-PB-22
25B-NBOMe
Escaline
MDAI
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
Experience:2 tabs DOB - My DOB Nightmare
DMT

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.